Deborah Beckwith v. HHS - Influenza, Guillain-Barre syndrome, Miller-Fisher variant (2026)

Deborah Beckwith filed a petition alleging that the influenza vaccine caused her to develop Guillain-Barré syndrome (GBS), specifically the Miller-Fisher variant. Initially, she claimed to have received multiple doses of the flu vaccine within a short period.

After significant procedural history, it was established that Ms. Beckwith received one dose of the flu vaccine in the early morning of September 24, 2019.

The core of her claim centered on proving causation-in-fact, as her GBS onset occurred less than three days after vaccination, precluding a presumption of causation under the Vaccine Injury Table. Ms.

Beckwith presented expert testimony from neurologists and immunologists who argued that an early onset of GBS following vaccination was medically acceptable, citing various studies and theories involving immune cell responses. The respondent, the Secretary of Health and Human Services, presented counter-expert testimony from neurologists and immunologists who opined that the typical immune response and antibody production required for GBS would take longer than the observed onset period, making a vaccine link unlikely.

The Chief Special Master denied entitlement, finding that Ms. Beckwith failed to prove by a preponderance of the evidence that her GBS onset occurred within a medically acceptable timeframe.

The court, on review, upheld the Chief Special Master's decision, agreeing that the evidence did not sufficiently establish a medically acceptable temporal relationship between the vaccination and the injury, and that the expert opinions supporting an early onset were not persuasive enough to meet the burden of proof. The case was ultimately denied.